111106-29-7 Usage
Uses
Used in Pharmaceutical Industry:
(+-)-3-((3,4-Dichlorobenzoyl)amino)-4-((3-methoxypropyl)pentylamino)-4-oxobutanoic acid is used as a CB1 receptor antagonist for the development of medications aimed at treating obesity and metabolic disorders. Its potency and selectivity make it a promising candidate for creating effective therapies that can help manage weight and improve metabolic health.
Used in Addiction Treatment:
In the field of addiction medicine, (+-)-3-((3,4-Dichlorobenzoyl)amino)-4-((3-methoxypropyl)pentylamino)-4-oxobutanoic acid is utilized as a therapeutic agent for the treatment of drug addiction and withdrawal symptoms. Its ability to modulate the CB1 receptor offers a potential pathway for managing cravings and aiding in the recovery process.
Used in Research and Development:
(+-)-3-((3,4-Dichlorobenzoyl)amino)-4-((3-methoxypropyl)pentylamino)-4-oxobutanoic acid is also used as a subject of research in scientific and academic settings. Its unique structure and properties make it an important compound for studying the mechanisms of cannabinoid receptor interactions and for developing new therapeutic strategies based on these findings.
Check Digit Verification of cas no
The CAS Registry Mumber 111106-29-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,1,0 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 111106-29:
(8*1)+(7*1)+(6*1)+(5*1)+(4*0)+(3*6)+(2*2)+(1*9)=57
57 % 10 = 7
So 111106-29-7 is a valid CAS Registry Number.
InChI:InChI=1/C20H28Cl2N2O5/c1-3-4-5-9-24(10-6-11-29-2)20(28)17(13-18(25)26)23-19(27)14-7-8-15(21)16(22)12-14/h7-8,12,17H,3-6,9-11,13H2,1-2H3,(H,23,27)(H,25,26)
